AI-generated summary
The authors describe a single patient with plaque psoriasis who responded poorly to etanercept and to etanercept combined with narrowband UVB phototherapy. After switching to excimer laser treatments twice weekly, the authors report a 75 percent PASI reduction at 4 weeks and over 95 percent clearance at 7 weeks. This is a single case report, so the findings cannot be generalized.
- Who or what was studied
- One patient with moderate-to-severe plaque psoriasis who had treatment failure with etanercept and NB-UVB
- Limits stated in the abstract
- The report describes a single patient, so no conclusions about effectiveness in other patients can be drawn.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Phototherapy, Laser, Ultraviolet. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.